Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Loxo Oncology CS (LOXO)

113.91 2.75 (2.47%)

02-23 16:00

Open:

111.99

Pre. Close:

111.16

High:

114.71

Low:

109.24

Volume:

204,249

Market Cap:

3410M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

114.882 - 115.345

115.345 - 115.823

Low:

108.137 - 108.603

108.603 - 109.084

Close:

113.121 - 113.956

113.956 - 114.818

Technical analysis  (as of: 2018-02-23 4:41:34 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 133.98     One year: 156.49

Support:

Support1: 96.48    Support2: 85.21

Resistance:

Resistance1: 114.71    Resistance2: 133.98

Pivot:

100.92

Moving Averages:

MA(5): 108.38     MA(20): 101.30

MA(100): 88.24     MA(250): 73.05

MACD:

MACD(12,26): 4.54     Signal(12,26,9): 3.39

%K %D:

%K(14,3): 90.05     %D(3): 84.33

RSI:

RSI(14): 72.74

52-Week:

High: 114.71  Low: 40.015  Change(%): 150.8

Average Vol(K):

3-Month: 37562  10-Days 37864

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
LOXO has closed below upper band by 2.5%. Bollinger Bands are 103.2% wider than normal. The large width of the bands suggest high volatility as compared to LOXO's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Wed, 21 Feb 2018 21:56:15 GMT
Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New ...

Fri, 23 Feb 2018 22:31:01 GMT
Loxo Oncology Inc. (LOXO) Breaks into New 52-Week High on February 23 Session

Thu, 22 Feb 2018 15:00:00 GMT
Loxo Oncology Reaches Analyst Target Price

Fri, 23 Feb 2018 18:37:17 GMT
NEJM publishes Loxo's larotrectinib clinical data

Tue, 13 Feb 2018 22:33:44 GMT
Loxo Oncology Inc. (LOXO) Moves Higher on Volume Spike for February 13

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

29.94

Shares Float (M)

29.54

% Held by Insiders

% Held by Institutions

Shares Short (K)

4336

Shares Short Prior Month (K)

3090

Stock Financials

EPS

-4.500

EPS Est. Current Year

-4.390

EPS Est. Next Year

-4.600

EPS Est. Next Quarter

-1.210

Forward EPS

-4.279

Book Value (p.s.)

7.960

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-53.6

Return on Equity (ttm)

-55.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-5.264

Qtrly Earnings Growth

Operating Cash Flow (M)

-128.01

Levered Free Cash Flow (M)

-71.64

atoplab.com

Valuation

P/E

-25.31

P/E Growth Ratio

0.02

P/BV

14.31

P/S

P/CF

-26.64

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.